國立成功大學 |
2012-05 |
Phase II study of adjuvant imatinib mesylate (IM) in patients after resection of primary gastrointestinal stromal tumor (GIST): Efficacy and safety at one year.
|
Yalcin, S (Yalcin, Suayib); Buyukberber, S (Buyukberber, Suleyman); Yilmaz, U (Yilmaz, Ugur); Lee, PH (Lee, Po-Huang); Srimuninnimit, V (Srimuninnimit, Vichien); Lin, PW (Lin, Pin-Wen); Elserafy, MM (Elserafy, Mostafa M.); Manieh, M (Manieh, Moustafa); Sunpaweravong, P (Sunpaweravong, Patrapim); Istomin, Y (Istomin, Yuriy); Sriuranpong, V (Sriuranpong, Virote); Hwang, TL (Hwang, Tsann-Long) |